The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
N | Nervous system | |
2
|
N07 | Other nervous system drugs | |
3
|
N07B | Drugs used in addictive disorders | |
4
|
N07BB | Drugs used in alcohol dependence | |
5
|
N07BB04 | Naltrexone |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Code | Route | Amount | Notes |
|---|---|---|---|
| ORAL | Oral | 50 mg |
| Active Ingredient |
|---|
|
Naltrexone is an orally used, long acting specific opioid antagonist. Naltrexone binds competitively to receptors which are located in the central and peripheral nervous system and hence blocks the access for exogenously administered opioids. |
| Document | Type | Information Source | |
|---|---|---|---|
| ADEPEND Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ETHYLEX Film-coated tablet | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| REVIA Tablet | MPI, CA: SPM | Health Products and Food Branch (CA) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.